Tengfei Li

Title: **Inventor Spotlight: Tengfei Li**

Introduction

Tengfei Li is an innovative inventor based in Shanghai, China, recognized for his contributions to pharmaceutical sciences. His work focuses on developing compounds that have significant applications in medicine, particularly in the treatment of diseases associated with HIF2-alpha activity.

Latest Patents

Li holds a notable patent titled "Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use." This patent encompasses compounds of a specific formula, including pharmaceutically acceptable salt forms. The invention details intermediates used in the preparation of these compounds, as well as the pharmaceutical compositions that utilize them. The compounds are proposed for treatment applications, highlighting their potential in addressing various health issues.

Career Highlights

Currently, Tengfei Li is associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to engage in cutting-edge research and development, contributing to the advancement of therapeutic solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Li has likely engaged in collaborations with fellow researchers and scientists within Novartis AG and other institutions. These partnerships are essential for fostering innovation and bringing novel therapeutic compounds to fruition.

Conclusion

Tengfei Li's work exemplifies the impact of innovative thinking in the pharmaceutical field. With his patent focusing on HIF2-alpha inhibition, he is paving the way for advancements in disease treatment methodologies. His career at Novartis AG underscores his commitment to improving healthcare through research and development.